Cargando…

Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2

Dlx2, Lymphoid Enhancer Factor (Lef-1) and Msx2 transcription factors are required for several developmental processes. To understand the control of gene expression by these factors, chromatin immunoprecipitation (ChIP) assays identified Msx2 as a downstream target of Dlx2 and Lef-1. Dlx2 activates...

Descripción completa

Detalles Bibliográficos
Autores principales: Diamond, Evan, Amen, Melanie, Hu, Qiaoyan, Espinoza, Herbert M., Amendt, Brad A.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1635299/
https://www.ncbi.nlm.nih.gov/pubmed/17068080
http://dx.doi.org/10.1093/nar/gkl689
_version_ 1782130681375096832
author Diamond, Evan
Amen, Melanie
Hu, Qiaoyan
Espinoza, Herbert M.
Amendt, Brad A.
author_facet Diamond, Evan
Amen, Melanie
Hu, Qiaoyan
Espinoza, Herbert M.
Amendt, Brad A.
author_sort Diamond, Evan
collection PubMed
description Dlx2, Lymphoid Enhancer Factor (Lef-1) and Msx2 transcription factors are required for several developmental processes. To understand the control of gene expression by these factors, chromatin immunoprecipitation (ChIP) assays identified Msx2 as a downstream target of Dlx2 and Lef-1. Dlx2 activates the Msx2 promoter in several cell lines and binds DNA as a monomer and dimer. A Lef-1 β-catenin-dependent isoform minimally activates the Msx2 promoter and a Lef-1 β-catenin-independent isoform is inactive, however co-expression of Dlx2 and both Lef-1 isoforms synergistically activate the Msx2 promoter. Co-immunoprecipitation and protein pull-down experiments demonstrate Lef-1 physically interacts with Dlx2. Deletion analyses of the Lef-1 protein reveal specific regions required for synergism with Dlx2. The Lef-1 β-catenin binding domain (βDB) is not required for its interaction with Dlx2. Msx2 can auto-regulate its promoter and repress Dlx2 activation. Msx2 repression of Dlx2 activation is dose-specific and both bind a common DNA-binding element. These transcriptional mechanisms correlate with the temporal and spatial expression of these factors and may provide a mechanism for the control of several developmental processes. We demonstrate new transcriptional activities for Dlx2, Msx2 and Lef-1 through protein interactions and identification of downstream targets.
format Text
id pubmed-1635299
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-16352992006-12-26 Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2 Diamond, Evan Amen, Melanie Hu, Qiaoyan Espinoza, Herbert M. Amendt, Brad A. Nucleic Acids Res Molecular Biology Dlx2, Lymphoid Enhancer Factor (Lef-1) and Msx2 transcription factors are required for several developmental processes. To understand the control of gene expression by these factors, chromatin immunoprecipitation (ChIP) assays identified Msx2 as a downstream target of Dlx2 and Lef-1. Dlx2 activates the Msx2 promoter in several cell lines and binds DNA as a monomer and dimer. A Lef-1 β-catenin-dependent isoform minimally activates the Msx2 promoter and a Lef-1 β-catenin-independent isoform is inactive, however co-expression of Dlx2 and both Lef-1 isoforms synergistically activate the Msx2 promoter. Co-immunoprecipitation and protein pull-down experiments demonstrate Lef-1 physically interacts with Dlx2. Deletion analyses of the Lef-1 protein reveal specific regions required for synergism with Dlx2. The Lef-1 β-catenin binding domain (βDB) is not required for its interaction with Dlx2. Msx2 can auto-regulate its promoter and repress Dlx2 activation. Msx2 repression of Dlx2 activation is dose-specific and both bind a common DNA-binding element. These transcriptional mechanisms correlate with the temporal and spatial expression of these factors and may provide a mechanism for the control of several developmental processes. We demonstrate new transcriptional activities for Dlx2, Msx2 and Lef-1 through protein interactions and identification of downstream targets. Oxford University Press 2006-11 2006-11-26 /pmc/articles/PMC1635299/ /pubmed/17068080 http://dx.doi.org/10.1093/nar/gkl689 Text en © 2006 The Author(s)
spellingShingle Molecular Biology
Diamond, Evan
Amen, Melanie
Hu, Qiaoyan
Espinoza, Herbert M.
Amendt, Brad A.
Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2
title Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2
title_full Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2
title_fullStr Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2
title_full_unstemmed Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2
title_short Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2
title_sort functional interactions between dlx2 and lymphoid enhancer factor regulate msx2
topic Molecular Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1635299/
https://www.ncbi.nlm.nih.gov/pubmed/17068080
http://dx.doi.org/10.1093/nar/gkl689
work_keys_str_mv AT diamondevan functionalinteractionsbetweendlx2andlymphoidenhancerfactorregulatemsx2
AT amenmelanie functionalinteractionsbetweendlx2andlymphoidenhancerfactorregulatemsx2
AT huqiaoyan functionalinteractionsbetweendlx2andlymphoidenhancerfactorregulatemsx2
AT espinozaherbertm functionalinteractionsbetweendlx2andlymphoidenhancerfactorregulatemsx2
AT amendtbrada functionalinteractionsbetweendlx2andlymphoidenhancerfactorregulatemsx2